| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.18 | 6e-07 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | 0.16 | 7e-06 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-05 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.23 | 1e-05 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.24 | 1e-05 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.19 | 0.0003 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |